SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001596771-20-000106
Filing Date
2020-11-09
Accepted
2020-11-09 15:57:05
Documents
2
Period of Report
2020-11-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1551
2 poamanuso.txt EX-24 2911
  Complete submission text file 0001596771-20-000106.txt   5904
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5130 ROUTE 212 WILLOW NY 12495
Business Address
MANUSO JAMES S J (Reporting) CIK: 0001236365 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 201297514